Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178253-17-000014
Filing Date
2017-07-05
Accepted
2017-07-05 15:55:37
Documents
1
Period of Report
2017-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149928452238964.html 4  
1 FORM 4 wf-form4_149928452238964.xml 4 3704
  Complete submission text file 0001178253-17-000014.txt   5082
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
McCourt Marion (Reporting) CIK: 0001663758 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 17947856